Publications

1. Crowley PD, Vaillant JJ, Shirley JD, Wengenack NL, Jo Kasten M. Rapidly growing knowledge of Mycobacterium smegmatis: A case series and review of antimicrobial susceptibility patterns. J Clin Tuberc Other Mycobact Dis. 2024 Dec; 37:100489 Epub 2024 Oct 22
   View PubMed
2. McHugh JW, Bayless DR, Ranganath N, Stevens RW, Kind DR, Wengenack NL, Shah AS. Candida guilliermondii fungemia: a 12-year retrospective review of antimicrobial susceptibility patterns at a reference laboratory and tertiary care center. J Clin Microbiol. 2024 Nov 13; 62 (11):e0105724 Epub 2024 Oct 23
   View PubMed
3. de Hoog S, Walsh TJ, Ahmed SA, Alastruey-Izquierdo A, Arendrup MC, Borman A, Chen S, Chowdhary A, Colgrove RC, Cornely OA, Denning DW, Dufresne PJ, Filkins L, Gangneux JP, Gene J, Groll AH, Guillot J, Haase G, Halliday C, Hawksworth DL, Hay R, Hoenigl M, Hubka V, Jagielski T, Kandemir H, Kidd SE, Kus JV, Kwon-Chung J, Lockhart SR, Meis JF, Mendoza L, Meyer W, Nguyen MH, Song Y, Sorrell TC, Stielow JB, Vilela R, Vitale RG, Wengenack NL, White PL, Ostrosky-Zeichner L, Zhang SX, ISHAM/ECMM/FDLC Working Group Nomenclature of Clinical Fungi. Nomenclature for human and animal fungal pathogens and diseases: a proposal for standardized terminology. J Clin Microbiol. 2024 Nov 11; e0093724 [Epub ahead of print]
   View PubMed
4. Yetmar ZA, Khodadadi RB, Chesdachai S, McHugh JW, Clement J, Challener DW, Wengenack NL, Bosch W, Seville MT, Beam E. Trimethoprim-sulfamethoxazole dosing and outcomes of pulmonary nocardiosis. Infection. 2024 Jun 26 Epub 2024 June 26
   View PubMed
5. Caldwell AT, Gabaldon T, Mixao V, Wengenack NL, Westley BP, Stevens RW. An inconspicuous identification: Isolation and identification of a novel Pichia species presenting as fungemia following cardiac surgery. Int J Infect Dis. 2024 Jun; 143:107040 Epub 2024 Apr 04
   View PubMed
6. de Hoog S, Walsh TJ, Ahmed SA, Alastruey-Izquierdo A, Alexander BD, Arendrup MC, Babady E, Bai FY, Balada-Llasat JM, Borman A, Chowdhary A, Clark A, Colgrove RC, Cornely OA, Dingle TC, Dufresne PJ, Fuller J, Gangneux JP, Gibas C, Glasgow H, Graser Y, Guillot J, Groll AH, Haase G, Hanson K, Harrington A, Hawksworth DL, Hayden RT, Hoenigl M, Hubka V, Johnson K, Kus JV, Li R, Meis JF, Lackner M, Lanternier F, Leal SM Jr, Lee F, Lockhart SR, Luethy P, Martin I, Kwon-Chung KJ, Meyer W, Nguyen MH, Ostrosky-Zeichner L, Palavecino E, Pancholi P, Pappas PG, Procop GW, Redhead SA, Rhoads DD, Riedel S, Stevens B, Sullivan KO, Vergidis P, Roilides E, Seyedmousavi A, Tao L, Vicente VA, Vitale RG, Wang QM, Wengenack NL, Westblade L, Wiederhold N, White L, Wojewoda CM, Zhang SX. Reply to Kidd et al., "Inconsistencies within the proposed framework for stabilizing fungal nomenclature risk further confusion". J Clin Microbiol 2024 Apr 10; 62 (4):e0162523 Epub 2024 Mar 05
   View PubMed
7. Yetmar ZA, Khodadadi RB, Chesdachai S, McHugh JW, Challener DW, Wengenack NL, Bosch W, Seville MT, Beam E. Epidemiology, Timing, and Secondary Prophylaxis of Recurrent Nocardiosis. Open Forum Infect Dis. 2024 Apr; 11 (4):ofae122 Epub 2024 Mar 01
   View PubMed
8. Ranganath N, Mendoza MA, Stevens R, Kind D, Wengenack N, Shah A. Rhodococcus infection: a 10-year retrospective analysis of clinical experience and antimicrobial susceptibility profile. J Clin Microbiol. 2024 Mar 13; 62 (3):e0153723 Epub 2024 Feb 13
   View PubMed
9. Ordaya EE, Abu Saleh OM, Vergidis P, Deml SM, Wengenack NL, Fida M. Temporal trends in antifungal susceptibility of Cryptococcus neoformans isolates from a reference laboratory in the United States, 2011-2021. Mycoses. 2024 Jan; 67 (1):e13691
   View PubMed
10. Khodadadi RB, McHugh JW, Chesdachai S, Wengenack NL, Bosch W, Seville MT, Osmon DR, Beam E, Yetmar ZA. Musculoskeletal infections associated with Nocardia species: a case series. J Bone Jt Infect. 2024; 9 (5):207-212 Epub 2024 Sept 24
    View PubMed
11. Wilcock JN, Gallagher AJ, Wengenack NL, Noyes CD, Klick JC, Wojewoda CM. Candida guilliermondii/Kodamaea ohmeri Endocarditis. Mycopathologia. 2023 Dec; 188 (6):907-908 Epub 2023 Aug 03
    View PubMed
12. de Hoog S, Walsh TJ, Ahmed SA, Alastruey-Izquierdo A, Alexander BD, Arendrup MC, Babady E, Bai FY, Balada-Llasat JM, Borman A, Chowdhary A, Clark A, Colgrove RC, Cornely OA, Dingle TC, Dufresne PJ, Fuller J, Gangneux JP, Gibas C, Glasgow H, Graser Y, Guillot J, Groll AH, Haase G, Hanson K, Harrington A, Hawksworth DL, Hayden RT, Hoenigl M, Hubka V, Johnson K, Kus JV, Li R, Meis JF, Lackner M, Lanternier F, Leal SM Jr, Lee F, Lockhart SR, Luethy P, Martin I, Kwon-Chung KJ, Meyer W, Nguyen MH, Ostrosky-Zeichner L, Palavecino E, Pancholi P, Pappas PG, Procop GW, Redhead SA, Rhoads DD, Riedel S, Stevens B, Sullivan KO, Vergidis P, Roilides E, Seyedmousavi A, Tao L, Vicente VA, Vitale RG, Wang QM, Wengenack NL, Westblade L, Wiederhold N, White L, Wojewoda CM, Zhang SX. A conceptual framework for nomenclatural stability and validity of medically important fungi: a proposed global consensus guideline for fungal name changes supported by ABP, ASM, CLSI, ECMM, ESCMID-EFISG, EUCAST-AFST, FDLC, IDSA, ISHAM, MMSA, and MSGERC. J Clin Microbiol. 2023 Nov 21; 61 (11):e0087323 Epub 2023 Oct 26
    View PubMed
13. Yetmar ZA, Chesdachai S, Khodadadi RB, McHugh JW, Challener DW, Wengenack NL, Bosch W, Seville MT, Beam E. Outcomes of transplant recipients with pretransplant Nocardia colonization or infection. Transpl Infect Dis. 2023 Oct; 25 (5):e14097 Epub 2023 June 28
    View PubMed
14. Chesdachai S, Yetmar ZA, Ranganath N, Everson JJ, Wengenack NL, Abu Saleh OM. Antifungal Susceptibility Pattern of Candida glabrata from a Referral Center and Reference Laboratory: 2012-2022. J Fungi (Basel). 2023 Aug 3; 9 (8) Epub 2023 Aug 03
    View PubMed
15. Yetmar ZA, Khodadadi RB, Chesdachai S, McHugh JW, Challener DW, Wengenack NL, Bosch W, Seville MT, Beam E. Mortality After Nocardiosis: Risk Factors and Evaluation of Disseminated Infection. Open Forum Infect Dis. 2023 Aug; 10 (8):ofad409 Epub 2023 Aug 01
    View PubMed
16. Brown-Elliott BA, Wallace RJ Jr, Wengenack NL, Workman SD, Cameron ADS, Bush G, Hughes MD, Melton S, Gonzalez-Ramirez B, Rodriguez E, Somayaji K, Klapperich C, Viers M, Bolaji AJ, Rempel E, Alexander DC. Emergence of Inducible Macrolide Resistance in Mycobacterium chelonae Due to Broad-Host-Range Plasmid and Chromosomal Variants of the Novel 23S rRNA Methylase Gene, erm(55). J Clin Microbiol. 2023 Jul 20; 61 (7):e0042823 Epub 2023 June 22
    View PubMed
17. El Zein S, Abu Saleh OM, Wengenack NL, Wilson JW. Clinical manifestations, treatment and outcomes of patients infected with Mycobacterium haemophilum with a focus on immune reconstitution inflammatory syndrome: a retrospective multi-site study. Infect Dis (Lond). 2023 Jul; 55 (7):467-479 Epub 2023 May 07
    View PubMed
18. Chesdachai S, Yetmar ZA, Tabaja H, Wengenack NL, Abu Saleh OM. Clinical characteristics of central nervous system phaeohyphomycosis: A brief report of 20 years' experience. Med Mycol. 2023 Jun 5; 61 (6)
    View PubMed
19. Dumais MG, Wengenack NL, Norgan AP, Amin S, Sia IG, Rhee PC, Connelly BJ, Arment CA. Toto, we're not in Kansas anymore: First reported case of M. persicum septic arthritis. J Clin Tuberc Other Mycobact Dis. 2023 May; 31:100352 Epub 2023 Mar 03
    View PubMed
20. Misra A, Yetmar ZA, Milone AA, Ruefthaler LA, Wengenack NL, Vergidis P, Theel ES. The Brief Case: the Cryptic Cryptococcus. J Clin Microbiol. 2023 Feb 22; 61 (2):e0054822
    View PubMed
21. Buckwalter SP, Connelly BJ, Louison LK, Kolesch JM, Herring SA, Woodliff ED, Bolster LaSalle CM, Grys TE, Deml SM, Wohlfiel SL, Steinmetz LK, Wengenack NL. Description, validation, and review of a decade of experience with a laboratory-developed PCR test for detection of Mycobacterium tuberculosis complex in pulmonary and extrapulmonary specimens. J Clin Tuberc Other Mycobact Dis. 2022 Dec; 29:100340 Epub 2022 Nov 12
    View PubMed
22. Flurin L, Wolf MJ, Mutchler MM, Daniels ML, Wengenack NL, Patel R. Targeted Metagenomic Sequencing-based Approach Applied to 2146 Tissue and Body Fluid Samples in Routine Clinical Practice. Clin Infect Dis. 2022 Nov 14; 75 (10):1800-1808
    View PubMed
23. Chatzopoulos K, Eschbacher KL, Gurram PR, Huang J, Rinaldo L, Milone AA, Johnson DR, Shah AS, Wengenack NL, Schuetz AN, Parney IF, Trejo-Lopez JA. An 82-year-old man with a right frontal lobe rim-enhancing lesion. Brain Pathol. 2022 Mar; 32 (2):e13021 Epub 2021 Oct 04
    View PubMed
24. Comba IY, Chesdachai S, Tabaja H, Mahmood M, Deml S, Wengenack NL, Wilson JW. Cardiovascular device infections due to rapidly growing Mycobacteria: A review of cases at a tertiary care hospital. J Clin Tuberc Other Mycobact Dis. 2022 Feb; 26:100296 Epub 2022 Jan 07
    View PubMed
25. Tai DBG, Wengenack NL, Patel R, Berbari EF, Abdel MP, Tande AJ. Fungal and mycobacterial cultures should not be routinely obtained for diagnostic work-up of patients with suspected periprosthetic joint infections. Bone Joint J. 2022 Jan; 104-B (1):53-58
    View PubMed
26. Fida M, Beam E, Wengenack NL. Misidentification of Mycobacterium smegmatis as Mycobacterium fortuitum by DNA line probe assay. J Clin Tuberc Other Mycobact Dis. 2021 Dec; 25:100268 Epub 2021 Aug 26
    View PubMed
27. Eberly AR, Natarjan U, Milone AA, Lucke MA, Canete-Gibas CF, Wiederhold NP, Wengenack NL. Answer to December 2021 Photo Quiz. J Clin Microbiol. 2021 Nov 18; 59 (12):e0289920
    View PubMed
28. Eberly AR, Natarjan U, Milone AA, Lucke MA, Canete-Gibas CF, Wiederhold NP, Wengenack NL. Photo Quiz: You Get What You Get, and Sometimes It's Tuberculate. J Clin Microbiol. 2021 Nov 18; 59 (12):e0289720
    View PubMed
29. O'Dowd TR, Mc Hugh JW, Theel ES, Wengenack NL, O'Horo JC, Enzler MJ, Vergidis P. Diagnostic Methods and Risk Factors for Severe Disease and Mortality in Blastomycosis: A Retrospective Cohort Study. J Fungi (Basel). 2021 Oct 20; 7(11).
    View PubMed
30. Wengenack NL, Koelsch JM, Steinmetz LK, Nesbitt JC, Freyholtz CD, Austin MD, O'Horo JC. Effects of Vaporized Hydrogen Peroxide Reprocessing on Quantitative Fit Performance of N95 Filtering Facepiece Respirators. Mayo Clin Proc Innov Qual Outcomes. 2021 Jun; 5(3):688-689. Epub 2021 Apr 30.
    View PubMed
31. Hamdi A, Fida M, Deml SM, Abu Saleh O, Wengenack NL. Utility of Mycobacterium tuberculosis PCR in ruling out active disease and impact on isolation requirements in a low prevalence setting. J Clin Tuberc Other Mycobact Dis. 2020 Dec; 21:100181 Epub 2020 Aug 17
    View PubMed
32. Go JR, Wengenack NL, Abu Saleh OM, Corsini Campioli C, Deml SM, Wilson JW. Mycobacterium septicum: a 6-Year Clinical Experience from a Tertiary Hospital and Reference Laboratory. J Clin Microbiol. 2020 Nov 18; 58 (12)
    View PubMed
33. Walchak RC, Buckwalter SP, Zinsmaster NM, Henn KM, Johnson KM, Koelsch JM, Herring SA, Steinmetz LK, Reed KA, Barth JE, Rasmusson JM, Fischer JL, Snippes Vagnone P, Sampathkumar P, Wengenack NL. Candida auris Direct Detection from Surveillance Swabs, Blood, and Urine Using a Laboratory-Developed PCR Method. J Fungi (Basel). 2020 Oct 15; 6 (4)
    View PubMed
34. Taylor J, Vagnone PS, Smith K, Walters J, Wengenack N, Deml S, Ferrieri P, Lynfield R. Characteristics of clinical extrapulmonary nontuberculous mycobacteria isolates in Minnesota, 2013-2017. Minn Med. 2020 Jun; 103 (3):39-43
    View PubMed
35. Hamdi AM, Fida M, Deml SM, Abu Saleh OM, Wengenack NL. Retrospective Analysis of Antimicrobial Susceptibility Profiles of Nocardia Species from a Tertiary Hospital and Reference Laboratory, 2011 to 2017. Antimicrob Agents Chemother. 2020 Feb 21; 64 (3)
    View PubMed
36. Jacobs SE, Wengenack NL, Walsh TJ. Non-Aspergillus Hyaline Molds: Emerging Causes of Sino-Pulmonary Fungal Infections and Other Invasive Mycoses. Semin Respir Crit Care Med. 2020 Feb; 41 (1):115-130 Epub 2020 Jan 30
    View PubMed
37. Jung S, Wengenack N, Shi M, Schuetz AN. Photo Quiz: Rapidly Progressive Pneumonia in a Resident of the U.S. Midwest. J Clin Microbiol 2019 Dec 23; 58 (1)
    View PubMed
38. Haydour Q, Hage CA, Carmona EM, Epelbaum O, Evans SE, Gabe LM, Knox KS, Kolls JK, Wengenack NL, Prokop LJ, Limper AH, Murad MH. Diagnosis of Fungal Infections. A Systematic Review and Meta-Analysis Supporting American Thoracic Society Practice Guideline. Ann Am Thorac Soc. 2019 Sep; 16 (9):1179-1188
    View PubMed
39. Shah AS, O'Horo JC, Tang S, Bryson AL, Wengenack NL, Sampathkumar P. Fungal Diagnostic Stewardship in Bronchoscopy Specimens for Immunocompetent Patients in the Intensive Care Unit. Mayo Clin Proc. 2019 Sep; 94 (9):1781-1785 Epub 2019 Aug 07
    View PubMed
40. Hage CA, Carmona EM, Epelbaum O, Evans SE, Gabe LM, Haydour Q, Knox KS, Kolls JK, Murad MH, Wengenack NL, Limper AH. Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary and Critical Care Practice. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2019 Sep 1; 200 (5):535-550
    View PubMed
41. Wilson JW, Jagtiani AC, Wengenack NL. Mycobacterium scrofulaceum disease: experience from a tertiary medical centre and review of the literature. Infect Dis (Lond). 2019 Aug; 51 (8):602-609 Epub 2019 July 02
    View PubMed
42. Espinel-Ingroff A, Turnidge J, Alastruey-Izquierdo A, Botterel F, Canton E, Castro C, Chen YC, Chen Y, Chryssanthou E, Dannaoui E, Garcia-Effron G, Gonzalez GM, Govender NP, Guinea J, Kidd S, Lackner M, Lass-Florl C, Linares-Sicilia MJ, Lopez-Soria L, Magobo R, Pelaez T, Quindos G, Rodriguez-Iglesia MA, Ruiz MA, Sanchez-Reus F, Sanguinetti M, Shields R, Szweda P, Tortorano A, Wengenack NL, Bramati S, Cavanna C, DeLuca C, Gelmi M, Grancini A, Lombardi G, Meletiadis J, Negri CE, Passera M, Peman J, Prigitano A, Sala E, Tejada M. Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in Candida and Aspergillus Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion Methods. Antimicrob Agents Chemother. 2019 Jan; 63 (1) Epub 2018 Dec 21
    View PubMed
43. Lau AF, Walchak RC, Miller HB, Slechta ES, Kamboj K, Riebe K, Robertson AE, Gilbreath JJ, Mitchell KF, Wallace MA, Bryson AL, Balada-Llasat JM, Bulman A, Buchan BW, Burnham CD, Butler-Wu S, Desai U, Doern CD, Hanson KE, Henderson CM, Kostrzewa M, Ledeboer NA, Maier T, Pancholi P, Schuetz AN, Shi G, Wengenack NL, Zhang SX, Zelazny AM, Frank KM. Multicenter Study Demonstrates Standardization Requirements for Mold Identification by MALDI-TOF MS. Front Microbiol. 2019; 10:2098 Epub 2019 Sept 20
    View PubMed
44. Gniadek TJ, Cappel MA, Wengenack NL, Libertin CR. Eumycetoma caused by Cladophialophora bantiana in the United States. Access Microbiol. 2019; 1 (7):e000030 Epub 2019 June 06
    View PubMed
45. Brown-Elliott BA, Simmer PJ, Trovato A, Hyle EP, Droz S, Buckwalter SP, Borroni E, Branda JA, Iana E, Mariottini A, Nelson J, Matteelli A, Toney NC, Scarparo C, de Man TJB, Vasireddy R, Gandhi RT, Wengenack NL, Cirillo DM, Wallace RJ, Tortoli E. Mycobacterium decipiens sp. nov., a new species closely related to the Mycobacterium tuberculosis complex. Int J Syst Evol Microbiol. 2018 Nov; 68 (11):3557-3562 Epub 2018 Sept 11
    View PubMed
46. Ramanan P, Virk A, Boland JM, Pritt B, Rizzo M, Wengenack NL. Photo Quiz: It's a Concrete Jungle Out There. J Clin Microbiol. 2018 Aug; 56 (8) Epub 2018 July 26
    View PubMed
47. Ramanan P, Virk A, Boland JM, Pritt B, Rizzo M, Wengenack NL. Answer to August 2018 Photo Quiz. J Clin Microbiol. 2018 Aug; 56 (8) Epub 2018 July 26
    View PubMed
48. Martin IW, Dionne K, Deml SM, Wengenack NL, Parrish NM. Automated broth-based systems versus the MYCOTB plate for antimicrobial susceptibility testing of the Mycobacterium tuberculosis complex: challenges in interpretation. Diagn Microbiol Infect Dis. 2018 May; 91 (1):38-41 Epub 2018 Jan 06
    View PubMed
49. Ramanan P, Wengenack NL, Theel ES. Laboratory Diagnostics for Fungal Infections: A Review of Current and Future Diagnostic Assays. Clin Chest Med. 2017 Sep; 38 (3):535-554 Epub 2017 May 31
    View PubMed
50. DeSimone DC, Heaton PR, Neff BA, Dao LN, Wengenack NL, Fadel HJ. A rare case of chronic otitis externa due to Mycobacterium tuberculosis. J Clin Tuberc Other Mycobact Dis. 2017 Aug; 8:13-15 Epub 2017 May 16
    View PubMed
51. Vasireddy R, Vasireddy S, Brown-Elliott BA, Wengenack NL, Eke UA, Benwill JL, Turenne C, Wallace RJ Jr. Mycobacterium arupense, mycobacterium heraklionense, and a newly proposed species, "mycobacterium virginiense" sp. nov., but not mycobacterium nonchromogenicum, as species of the mycobacterium terrae complex causing tenosynovitis and osteomyelitis (vol 54, pg 1340, 2016) Journal Of Clinical Microbiology. 2017 Mar; 55: (3)985.
    
52. Vasireddy R, Vasireddy S, Brown-Elliott BA, Wengenack NL, Eke UA, Benwill JL, Turenne C, Wallace RJ Jr. Correction for Vasireddy et al., Mycobacterium arupense, Mycobacterium heraklionense, and a Newly Proposed Species, "Mycobacterium virginiense" sp. nov., but Not Mycobacterium nonchromogenicum, as Species of the Mycobacterium terrae Complex Causing Tenosynovitis and Osteomyelitis. J Clin Microbiol. 2017 Mar; 55 (3):985
    View PubMed
53. Ramanan P, Vetter E, Milone AA, Patel R, Wengenack NL. Comparison of BACTEC MYCO/F Lytic Bottle to the Wampole Isolator for Recovery of Fungal and Mycobacterial Organisms Open Forum Infectious Diseases.2016;
    
54. Ramanan P, Gebrehiwot S, Rucinski S, Dylla B, Wengenack NL, Hughes J, Ihde S, Patel R. Discrepancies Between Microbial Detection and Identification Using the Blood Culture Identification FilmArray Panel Assay and Standard Subculture of Positive Blood Culture Bottles Open Forum Infectious Diseases.2016;
    
55. Tan N, Sampath R, Abu Saleh OM, Tweet MS, Jevremovic D, Alniemi S, Wengenack NL, Sampathkumar P, Badley AD. Disseminated Mycobacterium chimaera Infection After Cardiothoracic Surgery. Open Forum Infect Dis. 2016 Sep; 3 (3):ofw131 Epub 2016 June 16
    View PubMed
56. Simner PJ, Woods GL, Wengenack NL. Mycobacteria. Microbiol Spectr. 2016 Aug; 4 (4)
    View PubMed
57. Caulfield AJ, Wengenack NL. Diagnosis of active tuberculosis disease: From microscopy to molecular techniques. J Clin Tuberc Other Mycobact Dis. 2016 Aug; 4:33-43 Epub 2016 May 25
    View PubMed
58. Vasireddy R, Vasireddy S, Brown-Elliott BA, Wengenack NL, Eke UA, Benwill JL, Turenne C, Wallace RJ Jr. Mycobacterium arupense, Mycobacterium heraklionense, and a Newly Proposed Species, "Mycobacterium virginiense" sp. nov., but Not Mycobacterium nonchromogenicum, as Species of the Mycobacterium terrae Complex Causing Tenosynovitis and Osteomyelitis. J Clin Microbiol. 2016 May; 54 (5):1340-51 Epub 2016 Mar 09
    View PubMed
59. Simner PJ, Doerr KA, Steinmetz LK, Wengenack NL. Mycobacterium and Aerobic Actinomycete Culture: Are Two Medium Types and Extended Incubation Times Necessary? J Clin Microbiol. 2016 Apr; 54 (4):1089-93 Epub 2016 Feb 10
    View PubMed
60. Ghannoum M, Chaturvedi V, Diekema D, Ostrosky-Zeichner L, Rennie R, Walsh T, Wengenack N, Fothergill A, Wiederhold N. Multilaboratory Evaluation of In Vitro Antifungal Susceptibility Testing of Dermatophytes for ME1111. J Clin Microbiol. 2016 Mar; 54 (3):662-5 Epub 2015 Dec 30
    View PubMed
61. Buckwalter SP, Olson SL, Connelly BJ, Lucas BC, Rodning AA, Walchak RC, Deml SM, Wohlfiel SL, Wengenack NL. Evaluation of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Mycobacterium species, Nocardia species, and Other Aerobic Actinomycetes. J Clin Microbiol. 2016 Feb; 54 (2):376-84 Epub 2015 Dec 04
    View PubMed
62. Simner PJ, Woods GL, Wengenack NL. Mycobacteria Microbiology Spectrum. 2016; 4: (4)DMIH2-0016-2015.
    
63. Espinel-Ingroff A, Alvarez-Fernandez M, Canton E, Carver PL, Chen SC, Eschenauer G, Getsinger DL, Gonzalez GM, Govender NP, Grancini A, Hanson KE, Kidd SE, Klinker K, Kubin CJ, Kus JV, Lockhart SR, Meletiadis J, Morris AJ, Pelaez T, Quindos G, Rodriguez-Iglesias M, Sanchez-Reus F, Shoham S, Wengenack NL, Borrell Sole N, Echeverria J, Esperalba J, Gomez-G de la Pedrosa E, Garcia Garcia I, Linares MJ, Marco F, Merino P, Peman J, Perez Del Molino L, Rosello Mayans E, Rubio Calvo C, Ruiz Perez de Pipaon M, Yague G, Garcia-Effron G, Guinea J, Perlin DS, Sanguinetti M, Shields R, Turnidge J. Multicenter study of epidemiological cutoff values and detection of resistance in Candida spp. to anidulafungin, caspofungin, and micafungin using the Sensititre YeastOne colorimetric method. Antimicrob Agents Chemother. 2015 Nov; 59 (11):6725-32 Epub 2015 Aug 17
    View PubMed
64. Simner PJ, Hyle EP, Buckwalter SP, Branda JA, Brown-Elliott BA, Franklin J, Toney NC, de Man TJ, Wallace RJ Jr, Vasireddy R, Gandhi RT, Wengenack NL. Tenosynovitis caused by a novel nontuberculous Mycobacterium species initially misidentified as a member of the Mycobacterium tuberculosis complex. J Clin Microbiol. 2014 Dec; 52 (12):4414-8 Epub 2014 Sept 24
    View PubMed
65. Abidi MZ, Sohail MR, Cummins N, Wilhelm M, Wengenack N, Brumble L, Shah H, Jane Hata D, McCullough A, Wendel A, Vikram HR, Kusne S, Litzow M, Letendre L, Lahr BD, Poeschla E, Walker RC. Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high-risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin-amphotericin combination therapies. Mycoses. 2014 Nov; 57 (11):687-98 Epub 2014 July 18
    View PubMed
66. Nagpal A, Wentink JE, Berbari EF, Aronhalt KC, Wright AJ, Krageschmidt DA, Wengenack NL, Thompson RL, Tosh PK. A cluster of Mycobacterium wolinskyi surgical site infections at an academic medical center. Infect Control Hosp Epidemiol. 2014 Sep; 35: (9)1169-75.
    View PubMed
67. Beam E, Vasoo S, Simner PJ, Rizzo M, Mason EL, Walker RC, Deml SM, Brown-Elliott BA, Wallace RJ Jr, Wengenack NL, Sia IG. Mycobacterium arupense flexor tenosynovitis: case report and review of antimicrobial susceptibility profiles for 40 clinical isolates. J Clin Microbiol. 2014 Jul; 52 (7):2706-8 Epub 2014 Apr 30
    View PubMed
68. Khare R, Gupta S, Arif S, Jentoft ME, Deziel PJ, Roden AC, Wilhelm MP, Razonable RR, Wengenack NL. Misidentification of Neosartorya pseudofischeri as Aspergillus fumigatus in a lung transplant patient. J Clin Microbiol. 2014 Jul; 52 (7):2722-5 Epub 2014 May 14
    View PubMed
69. Buckwalter SP, Sloan LM, Cunningham SA, Espy MJ, Uhl JR, Jones MF, Vetter EA, Mandrekar J, Cockerill FR 3rd, Pritt BS, Patel R, Wengenack NL. Inhibition controls for qualitative real-time PCR assays: are they necessary for all specimen matrices? J Clin Microbiol. 2014 Jun; 52 (6):2139-43 Epub 2014 Apr 16
    View PubMed
70. Ramanan P, Khare R, Tosh PK, Wilson JW, Wengenack NL. A 36 year old female from Kuwait with AIDS presenting with fever and abdominal pain Journal of medical microbiology case reports. 2014.
    
71. Sia IG, Buckwalter SP, Doerr KA, Lugos S, Kramer R, Orillaza-Chi R, Quelapio MI, Tupasi TE, Wengenack NL. Genotypic characteristics of Mycobacterium tuberculosis isolated from household contacts of tuberculosis patients in the Philippines. BMC Infect Dis. 2013 Dec 5; 13:571 Epub 2013 Dec 05
    View PubMed
72. Simner PJ, Buckwalter SP, Uhl JR, Wengenack NL, Pritt BS. Detection and identification of yeasts from formalin-fixed, paraffin-embedded tissue by use of PCR-electrospray ionization mass spectrometry. J Clin Microbiol. 2013 Nov; 51 (11):3731-4 Epub 2013 Aug 28
    View PubMed
73. Simner PJ, Buckwalter SP, Uhl JR, Wengenack NL. Identification of Mycobacterium species and Mycobacterium tuberculosis complex resistance determinants by use of PCR-electrospray ionization mass spectrometry. J Clin Microbiol. 2013 Nov; 51 (11):3492-8 Epub 2013 Aug 14
    View PubMed
74. Ramanan P, Deziel PJ, Wengenack NL. Gordonia bacteremia. J Clin Microbiol. 2013 Oct; 51(10):3443-7. Epub 2013 Jul 24.
    View PubMed
75. Mukhopadhyay S, Wilcox BE, Myers JL, Bryant SC, Buckwalter SP, Wengenack NL, Yi ES, Aughenbaugh GL, Specks U, Aubry MC. Pulmonary necrotizing granulomas of unknown cause: clinical and pathologic analysis of 131 patients with completely resected nodules. Chest. 2013 Sep; 144 (3):813-824
    View PubMed
76. Simner PJ, Uhl JR, Hall L, Weber MM, Walchak RC, Buckwalter S, Wengenack NL. Broad-range direct detection and identification of fungi by use of the PLEX-ID PCR-electrospray ionization mass spectrometry (ESI-MS) system. J Clin Microbiol. 2013 Jun; 51 (6):1699-706 Epub 2013 Mar 20
    View PubMed
77. Theel ES, Jespersen DJ, Iqbal S, Bestrom JE, Rollins LO, Misner LJ, Markley BJ, Mandrekar J, Baddour LM, Limper AH, Wengenack NL, Binnicker MJ. Detection of (1, 3)-beta-D-glucan in bronchoalveolar lavage and serum samples collected from immunocompromised hosts. Mycopathologia. 2013 Feb; 175 (1-2):33-41 Epub 2012 Sept 01
    View PubMed
78. Anderson JH, Boyce TG, Wengenack NL, Driscoll CLW, Fischer PR. Mycobacterium abscessus infection of a cochlear implant insertion site. International Journal of Pediatric Otorhinolaryngology Extra. 2013; 8(4):122-4.
    
79. Wentworth AB, Drage LA, Wengenack NL, Wilson JW, Lohse CM. Increased incidence of cutaneous nontuberculous mycobacterial infection, 1980 to 2009: a population-based study. Mayo Clin Proc. 2013 Jan; 88 (1):38-45 Epub 2012 Dec 04
    View PubMed
80. Hall L, Jude KP, Clark SL, Dionne K, Merson R, Boyer A, Parrish NM, Wengenack NL. Evaluation of the Sensititre MycoTB plate for susceptibility testing of the Mycobacterium tuberculosis complex against first- and second-line agents. J Clin Microbiol. 2012 Nov; 50 (11):3732-4 Epub 2012 Aug 15
    View PubMed
81. Theel ES, Schmitt BH, Hall L, Cunningham SA, Walchak RC, Patel R, Wengenack NL. Formic acid-based direct, on-plate testing of yeast and Corynebacterium species by Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol. 2012 Sep; 50 (9):3093-5 Epub 2012 July 03
    View PubMed
82. McTaggart LR, Wengenack NL, Richardson SE. Validation of the MycAssay Pneumocystis kit for detection of Pneumocystis jirovecii in bronchoalveolar lavage specimens by comparison to a laboratory standard of direct immunofluorescence microscopy, real-time PCR, or conventional PCR. J Clin Microbiol. 2012 Jun; 50(6):1856-9. Epub 2012 Mar 14.
    View PubMed
83. Seah C, Richardson SE, Tsui G, Yu B, Thornback J, McTaggart L, Boggild A, Wengenack NL, Zhang SX. Comparison of the FXG: RESP (Asp+) real-time PCR assay with direct immunofluorescence and calcofluor white staining for the detection of Pneumocystis jirovecii in respiratory specimens. Med Mycol. 2012 Apr; 50(3):324-7. Epub 2011 Aug 23.
    View PubMed
84. Conville PS, Brown-Elliott BA, Wallace RJ Jr, Witebsky FG, Koziol D, Hall GS, Killian SB, Knapp CC, Warshauer D, Van T, Wengenack NL, Deml S, Woods GL. Multisite reproducibility of the broth microdilution method for susceptibility testing of Nocardia species. J Clin Microbiol. 2012 Apr; 50(4):1270-80. Epub 2012 Jan 04.
    View PubMed
85. Hall L, Le Febre KM, Deml SM, Wohlfiel SL, Wengenack NL. Evaluation of the Yeast Traffic Light PNA FISH probes for identification of Candida species from positive blood cultures. J Clin Microbiol. 2012 Apr; 50 (4):1446-8 Epub 2012 Jan 11
    View PubMed
86. Brown-Elliott BA, Biehle J, Conville PS, Cohen S, Saubolle M, Sussland D, Wengenack N, Kriel K, Bridge L, McNulty S, Vasireddy R, Wallace RJ Jr. Sulfonamide resistance in isolates of Nocardia spp. from a US multicenter survey. J Clin Microbiol. 2012 Mar; 50(3):670-2. Epub 2011 Dec 14.
    View PubMed
87. Theel ES, Hall L, Mandrekar J, Wengenack NL. Dermatophyte identification using matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol. 2011 Dec; 49 (12):4067-71 Epub 2011 Sept 28
    View PubMed
88. Ariza-Heredia EJ, Dababneh AS, Wilhelm MP, Wengenack NL, Razonable RR, Wilson JW. Mycobacterium wolinskyi: a case series and review of the literature. Diagn Microbiol Infect Dis. 2011 Dec; 71(4):421-7. Epub 2011 Sep 25.
    View PubMed
89. Santillan Salas CF, Joshi AY, Dhiman N, Banerjee R, Huskins WC, Wengenack NL, Henry NK. Fatal post-operative Trichoderma longibrachiatum mediastinitis and peritonitis in a paediatric patient with complex congenital cardiac disease on peritoneal dialysis. J Med Microbiol. 2011 Dec; 60 (Pt 12):1869-1871 Epub 2011 July 28
    View PubMed
90. Hage CA, Ribes JA, Wengenack NL, Baddour LM, Assi M, McKinsey DS, Hammoud K, Alapat D, Babady NE, Parker M, Fuller D, Noor A, Davis TE, Rodgers M, Connolly PA, El Haddad B, Wheat LJ. A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis. 2011 Sep; 53(5):448-54. Epub 2011 Aug 02.
    View PubMed
91. Babady NE, Buckwalter SP, Hall L, Le Febre KM, Binnicker MJ, Wengenack NL. Detection of Blastomyces dermatitidis and Histoplasma capsulatum from culture isolates and clinical specimens by use of real-time PCR. J Clin Microbiol. 2011 Sep; 49 (9):3204-8 Epub 2011 July 13
    View PubMed
92. Doskaya M, Caner A, Degirmenci A, Wengenack NL, Yolasigmaz A, Turgay N, Ozensoy Toz S, Guruz Y. Degree and frequency of inhibition in a routine real-time PCR detecting Pneumocystis jirovecii for the diagnosis of Pneumocystis pneumonia in Turkey. J Med Microbiol. 2011 Jul; 60 (Pt 7):937-944 Epub 2011 Apr 01
    View PubMed
93. Hall L, Jude KP, Clark SL, Wengenack NL. Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex for first and second line drugs by broth dilution in a microtiter plate format. J Vis Exp. 2011 Jun 24; (52) Epub 2011 June 24
    View PubMed
94. Dhiman N, Hall L, Wohlfiel SL, Buckwalter SP, Wengenack NL. Performance and cost analysis of matrix-assisted laser desorption ionization-time of flight mass spectrometry for routine identification of yeast. J Clin Microbiol. 2011 Apr; 49 (4):1614-6 Epub 2011 Jan 26
    View PubMed
95. Binnicker MJ, Popa AS, Catania J, Alexov M, Tsaras G, Lloyd F, Wengenack NL, Enzler MJ. Meningeal coccidioidomycosis diagnosed by real-time polymerase chain reaction analysis of cerebrospinal fluid. Mycopathologia. 2011 Apr; 171 (4):285-9 Epub 2010 Oct 07
    View PubMed
96. Khoury NZ, Binnicker MJ, Wengenack NL, Aksamit TR, Buchta WG, Molella RG. Preemployment screening for tuberculosis in a large health care setting: comparison of the tuberculin skin test and a whole-blood interferon-gamma release assay. J Occup Environ Med. 2011 Mar; 53(3):290-3.
    View PubMed
97. Wilson JW, Limper AH, Grys TE, Karre T, Wengenack NL, Binnicker MJ. Pneumocystis jirovecii testing by real-time polymerase chain reaction and direct examination among immunocompetent and immunosuppressed patient groups and correlation to disease specificity. Diagn Microbiol Infect Dis. 2011 Feb; 69 (2):145-52
    View PubMed
98. Vucicevic D, Blair JE, Binnicker MJ, McCullough AE, Kusne S, Vikram HR, Parish JM, Wengenack NL. The utility of Coccidioides polymerase chain reaction testing in the clinical setting. Mycopathologia. 2010 Nov; 170 (5):345-51 Epub 2010 June 10
    View PubMed
99. Boyce RD, Deziel PJ, Otley CC, Wilhelm MP, Eid AJ, Wengenack NL, Razonable RR. Phaeohyphomycosis due to Alternaria species in transplant recipients. Transpl Infect Dis. 2010 Jun; 12 (3):242-50 Epub 2009 Dec 09
    View PubMed
100. Babady NE, Hall L, Abbenyi AT, Eisberner JJ, Brown-Elliott BA, Pratt CJ, McGlasson MC, Beierle KD, Wohlfiel SL, Deml SM, Wallace RJ Jr, Wengenack NL. Evaluation of Mycobacterium avium complex clarithromycin susceptibility testing using SLOMYCO Sensititre panels and JustOne strips. J Clin Microbiol. 2010 May; 48 (5):1749-52 Epub 2010 Mar 24
     View PubMed
101. Forgacs P, Zimmerman SK, Silverman ML, Wengenack NL, Hall L, Roberts GD. Authors' reply. Antimicrob Agents Chemother. 2010; 54(6):2748-9.
     
102. Sia IG, Orillaza RB, St Sauver JL, Quelapio ID, Lahr BD, Alcaneses RS, Wilson WR, Cockerill FR, Balane GI, Mangubat NV, Wengenack NL, Tupasi TE. Tuberculosis attributed to household contacts in the Philippines. Int J Tuberc Lung Dis. 2010 Jan; 14 (1):122-5
     View PubMed
103. Klein KR, Hall L, Deml SM, Rysavy JM, Wohlfiel SL, Wengenack NL. Identification of Cryptococcus gattii by use of L-canavanine glycine bromothymol blue medium and DNA sequencing. J Clin Microbiol. 2009 Nov; 47 (11):3669-72 Epub 2009 Sept 30
     View PubMed
104. Forgacs P, Wengenack NL, Hall L, Zimmerman SK, Silverman ML, Roberts GD. Tuberculosis and trimethoprim-sulfamethoxazole. Antimicrob Agents Chemother. 2009 Nov; 53(11):4789-93. Epub 2009 Jun 29.
     View PubMed
105. Wengenack NL, Binnicker MJ. Fungal molecular diagnostics. Clin Chest Med. 2009 Jun; 30 (2):391-408, viii
     View PubMed
106. Babady NE, Bestrom JE, Jespersen DJ, Jones MF, Beito EM, Binnicker MJ, Wengenack NL. Evaluation of three commercial latex agglutination kits and a commercial enzyme immunoassay for the detection of cryptococcal antigen. Med Mycol. 2009 May; 47 (3):336-8 Epub 2009 Feb 04
     View PubMed
107. Hata DJ, Buckwalter SP, Pritt BS, Roberts GD, Wengenack NL. Real-time PCR method for detection of zygomycetes. J Clin Microbiol. 2008 Jul; 46 (7):2353-8 Epub 2008 May 14
     View PubMed
108. Hall L, Otter JA, Chewins J, Wengenack NL. Deactivation of the dimorphic fungi Histoplasma capsulatum, Blastomyces dermatitidis and Coccidioides immitis using hydrogen peroxide vapor. Med Mycol. 2008 Mar; 46(2):189-91.
     View PubMed
109. Eid AJ, Berbari EF, Sia IG, Wengenack NL, Osmon DR, Razonable RR. Prosthetic joint infection due to rapidly growing mycobacteria: report of 8 cases and review of the literature. Clin Infect Dis. 2007 Sep 15; 45(6):687-94. Epub 2007 Aug 13.
     View PubMed
110. Assi MA, Berg JC, Marshall WF, Wengenack NL, Patel R. Mycobacterium gordonae pulmonary disease associated with a continuous positive airway pressure device. Transpl Infect Dis. 2007 Sep; 9(3):249-52. Epub 2007 Jul 01.
     View PubMed
111. Hata DJ, Hall L, Fothergill AW, Larone DH, Wengenack NL. Multicenter evaluation of the new VITEK 2 advanced colorimetric yeast identification card. J Clin Microbiol. 2007 Apr; 45 (4):1087-92 Epub 2007 Jan 31
     View PubMed
112. Hall L, Otter JA, Chewins J, Wengenack NL. Use of hydrogen peroxide vapor for deactivation of Mycobacterium tuberculosis in a biological safety cabinet and a room. J Clin Microbiol. 2007 Mar; 45 (3):810-5 Epub 2006 Dec 13
     View PubMed
113. Binnicker MJ, Buckwalter SP, Eisberner JJ, Stewart RA, McCullough AE, Wohlfiel SL, Wengenack NL. Detection of Coccidioides species in clinical specimens by real-time PCR. J Clin Microbiol. 2007 Jan; 45 (1):173-8 Epub 2006 Nov 15
     View PubMed
114. Blair JE, Coakley B, Santelli AC, Hentz JG, Wengenack NL. Serologic testing for symptomatic coccidioidomycosis in immunocompetent and immunosuppressed hosts. Mycopathologia. 2006 Nov; 162 (5):317-24
     View PubMed
115. Uslan DZ, Kowalski TJ, Wengenack NL, Virk A, Wilson JW. Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility. Arch Dermatol. 2006 Oct; 142(10):1287-92.
     View PubMed
116. Assi MA, Binnicker MJ, Wengenack NL, Deziel PJ, Badley AD. Disseminated coccidioidomycosis in a liver transplant recipient with negative serology: use of polymerase chain reaction. Liver Transpl. 2006 Aug; 12 (8):1290-2
     View PubMed
117. Pietila MP, Vohra PK, Sanyal B, Wengenack NL, Raghavakaimal S, Thomas CF Jr. Cloning and characterization of CYP51 from Mycobacterium avium. Am J Respir Cell Mol Biol. 2006 Aug; 35 (2):236-42 Epub 2006 Mar 16
     View PubMed
118. Edson RS, Terrell CL, Brutinel WM, Wengenack NL. Mycobacterium intermedium granulomatous dermatitis from hot tub exposure. Emerg Infect Dis. 2006 May; 12 (5):821-3
     View PubMed
119. Arcenas RC, Uhl JR, Buckwalter SP, Limper AH, Crino D, Roberts GD, Wengenack NL. A real-time polymerase chain reaction assay for detection of Pneumocystis from bronchoalveolar lavage fluid. Diagn Microbiol Infect Dis. 2006 Mar; 54 (3):169-75 Epub 2006 Jan 19
     View PubMed
120. Espy MJ, Uhl JR, Sloan LM, Buckwalter SP, Jones MF, Vetter EA, Yao JD, Wengenack NL, Rosenblatt JE, Cockerill FR 3rd, Smith TF. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev. 2006 Jan; 19 (1):165-256
     View PubMed
121. Wengenack NL, Lane BD, Hill PJ, Uhl JR, Lukat-Rodgers GS, Hall L, Roberts GD, Cockerill FR 3rd, Brennan PJ, Rodgers KR, Belisle JT, Rusnak F. Purification and characterization of Mycobacterium tuberculosis KatG, KatG(S315T), and Mycobacterium bovis KatG(R463L). Protein Expr Purif. 2004 Aug; 36: (2)232-43.
     View PubMed
122. Wolk DM, Schneider SK, Wengenack NL, Sloan LM, Rosenblatt JE. Real-time PCR method for detection of Encephalitozoon intestinalis from stool specimens. J Clin Microbiol. 2002 Nov; 40 (11):3922-8
     View PubMed
123. Bulatovic VM, Wengenack NL, Uhl JR, Hall L, Roberts GD, Cockerill FR 3rd, Rusnak F. Oxidative stress increases susceptibility of Mycobacterium tuberculosis to isoniazid. Antimicrob Agents Chemother. 2002 Sep; 46 (9):2765-71
     View PubMed
124. Wengenack NL, Pierce T, Roberts GD. Identification of Rhizopus zygospores from a skin graft. Journal of Medical Mycology. 2002; 12:136-7.
     
125. Rodgers KR, Tang L, Lukat-Rodgers GS, Wengenack NL. Insights into the signal transduction mechanism of RmFixL provided by carbon monoxide recombination kinetics. Biochemistry. 2001 Oct 30; 40(43):12932-42.
     View PubMed
126. Wengenack NL, Rusnak F, Rusnak F. Evidence for isoniazid-dependent free radical generation catalyzed by Mycobacterium tuberculosis KatG and the isoniazid-resistant mutant KatG(S315T). Biochemistry. 2001 Jul 31; 40 (30):8990-6
     View PubMed
127. Lukat-Rodgers GS, Wengenack NL, Rusnak F, Rodgers KR. Carbon monoxide adducts of KatG and KatG(S315T) as probes of the heme site and isoniazid binding. Biochemistry. 2001 Jun 19; 40(24):7149-57.
     View PubMed
128. Wengenack NL, Lopes H, Kennedy MJ, Tavares P, Pereira AS, Moura I, Moura JJ, Rusnak F, Rusnak F. Redox potential measurements of the Mycobacterium tuberculosis heme protein KatG and the isoniazid-resistant enzyme KatG(S315T): insights into isoniazid activation. Biochemistry. 2000 Sep 19; 39 (37):11508-13
     View PubMed
129. Lukat-Rodgers GS, Wengenack NL, Rusnak F, Rodgers KR. Spectroscopic comparison of the heme active sites in WT KatG and its S315T mutant. Biochemistry. 2000 Aug 15; 39(32):9984-93.
     View PubMed
130. Wengenack NL, Hoard HM, Rusnak F. Isoniazid oxidation by Mycobacterium tuberculosis KatG: a role for superoxide which correlates with isoniazid susceptibility. J Am Chem Soc. 1999 Oct 20; 121(41):9748-9749.
     
131. Wengenack NL, Jensen MP, Rusnak F, Stern MK. Mycobacterium tuberculosis KatG is a peroxynitritase. Biochem Biophys Res Commun. 1999 Mar 24; 256(3):485-7.
     View PubMed
132. Wengenack NL, Todorovic S, Yu L, Rusnak F. Evidence for differential binding of isoniazid by Mycobacterium tuberculosis KatG and the isoniazid-resistant mutant KatG(S315T). Biochemistry. 1998 Nov 10; 37(45):15825-34.
     View PubMed
133. Wengenack NL, Uhl JR, St Amand AL, Tomlinson AJ, Benson LM, Naylor S, Kline BC, Cockerill FR 3rd, Rusnak F, Rusnak F. Recombinant Mycobacterium tuberculosis KatG(S315T) is a competent catalase-peroxidase with reduced activity toward isoniazid. J Infect Dis. 1997 Sep; 176 (3):722-7
     View PubMed